Flush With Fresh Funds, ReViral CEO Outlines RSV Trial Plans

 
• By Sten Stovall
  
SC1808_Sick Boy_730035700_1200.jpg
ReViral to test RV521 in babies aged one to 24 months. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business